The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Marson, Justin WManer, Brittany S
Harding, Tanner P
Meisenheimer, John
Solomon, James A
Leavitt, Matt
Levin, Nicole J
Dellavalle, Robert
Brooks, Ian
Rigel, Darrell S
Keyword
COVID-19basal cell carcinoma
cutaneous melanoma
cutaneous squamous cell carcinoma
diagnostic delay
nonmelanoma skin cancer
Journal title
Journal of the American Academy of DermatologyDate Published
2021-01-19Publication Volume
84Publication Issue
4Publication Begin page
1100Publication End page
1103
Metadata
Show full item recordCitation
Marson JW, Maner BS, Harding TP, Meisenheimer J VII, Solomon JA, Leavitt M, Levin NJ, Dellavalle R, Brooks I, Rigel DS. The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers. J Am Acad Dermatol. 2021 Apr;84(4):1100-1103. doi: 10.1016/j.jaad.2020.12.065. Epub 2021 Jan 19. PMID: 33482258; PMCID: PMC7817517.DOI
10.1016/j.jaad.2020.12.065ae974a485f413a2113503eed53cd6c53
10.1016/j.jaad.2020.12.065
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International